DocGo (DCGO) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
8 Jul, 2026Executive summary
Q3 2024 revenue was $138.7 million, down about 26% year-over-year due to the planned wind-down of migrant-related projects, but year-to-date revenue rose 17% to $495.7 million.
Net income for Q3 2024 was $4.5 million, nearly flat year-over-year; year-to-date net income surged to $21.0 million from $2.1 million in 2023, driven by expanded Mobile Health Services and improved cost management.
Adjusted EBITDA for Q3 2024 increased to $17.9 million, with margin improving to 12.9%; year-to-date adjusted EBITDA rose 88% to $59.2 million.
Expanded operational footprint with new hubs on the West Coast and Northeast, and care gap closure programs now exceed 500,000 assigned lives, with weekly visits doubling sequentially.
Major contract expansions and new program launches with key payers and partners, including L.A. Care and Atlantic City 911 services.
Financial highlights
Q3 2024 revenue: $138.7 million (down 25.7% year-over-year); year-to-date: $495.7 million (up 16.6%).
Q3 2024 net income: $4.5 million; year-to-date: $21.0 million (up from $2.1 million in 2023).
Q3 2024 adjusted EBITDA: $17.9 million; margin: 12.9% (up from 8.9% in Q3 2023).
Q3 2024 adjusted gross margin: 36% (up from 29.5% year-over-year); mobile health segment margin at 38.8%, transportation at 30.7%.
Cash and equivalents rose to $108.6 million at quarter end, up from $85.8 million in Q2 and $59 million in Q1.
Outlook and guidance
2024 revenue guidance narrowed to $620–$630 million; adjusted EBITDA expected at $70–$75 million; cash flow from operations guidance raised to $90–$100 million.
Migrant-related revenue for 2024 expected at $360–$390 million, with base business at $240–$260 million.
2025 consolidated revenue guidance set at $410–$450 million, including $50 million from migrant-related work, with adjusted EBITDA margin projected at 8–10%.
Mobile Health Services revenue expected to decline further in Q4 2024 as migrant-related projects wind down, while Transportation Services trip volumes are expected to grow.
Latest events from DocGo
- Q2 revenue up 31% to $164.9M, net income and margins rose, cash flow guidance increased.DCGO
Q2 20249 Jul 2026 - Record growth, board transition, and tech-driven initiatives mark a pivotal year.DCGO
AGM 202617 Jun 2026 - Transitioning to proactive, tech-enabled care, the company targets growth and profitability.DCGO
Goldman Sachs 47th Annual Global Healthcare Conference 20268 Jun 2026 - Tech-driven healthcare platform posts strong growth, raises guidance, and targets profitability.DCGO
21st Annual Needham Technology, Media, & Consumer Conference14 May 2026 - Rapidly scaling mobile healthcare and transport with strong growth, tech integration, and expanding margins.DCGO
Investor presentation14 May 2026 - Q1 revenue was $75.6M, net loss widened, but 2026 guidance was raised on strong core growth.DCGO
Q1 202611 May 2026 - Key votes include director elections, reverse stock split, and auditor ratification for 2026.DCGO
Proxy filing23 Apr 2026 - Proxy seeks approval for director elections, reverse stock split, and key governance amendments.DCGO
Proxy filing22 Apr 2026 - Key proposals include director elections, a reverse stock split, and governance amendments.DCGO
Proxy filing10 Apr 2026